These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 782976)

  • 21. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK
    Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral typhoid vaccine. Acambis/Berna.
    Witherell GW
    Curr Opin Investig Drugs; 2003 Aug; 4(8):1010-8. PubMed ID: 14508886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of effectivity of oral killed typhoid and paratyphoid b vaccines and aerosol chemical thyphoid vaccine in controlled field trials.
    Hejfets LB; Levina LA; Salmin LV; Antonova AA; Segal LS; Kuzminova ML; Slavina KM; Vasileva AV
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):292-9. PubMed ID: 827582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of oral inactivated typhoid vaccine.
    Grahneis H
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):129-33. PubMed ID: 4440522
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2.
    Wahdan MH; Sippel JE; Mikhail IA; Rahka AE; Anderson ES; Sparks HA; Cvjetanović B
    Bull World Health Organ; 1975; 52(1):69-73. PubMed ID: 1082383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].
    Cryz SJ; Fürer E; Levine MM
    Schweiz Med Wochenschr; 1988 Apr; 118(13):467-70. PubMed ID: 3375787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ineffectiveness of an oral killed typhoid vaccine in a field trial.
    Chuttani CS; Prakash K; Vergese A; Gupta P; Chawla RK; Grover V; Agarwal DS
    Bull World Health Organ; 1973 Jun; 48(6):754-5. PubMed ID: 4594320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
    Frey SE; Bollen W; Sizemore D; Campbell M; Curtiss R
    Clin Immunol; 2001 Oct; 101(1):32-7. PubMed ID: 11580224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine.
    Hejfec LB; Levina LA; Kuz'minova ML; Salmin LV; Slavina AM; Vasil'eva AV
    Bull World Health Organ; 1968; 38(6):907-15. PubMed ID: 4973021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled field trial of a high-dose oral killed typhoid vaccine in India.
    Chuttani CS; Prakash K; Gupta P; Grover V; Kumar A
    Bull World Health Organ; 1977; 55(5):643-4. PubMed ID: 338191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cell mediated immunity to porins from Salmonella typhi.
    Blanco F; Isibasi A; Raúl González C; Ortiz V; Paniagua J; Arreguín C; Kumate J
    Scand J Infect Dis; 1993; 25(1):73-80. PubMed ID: 8384733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular immunity against Salmonella typhi after live oral vaccine.
    Nencioni L; Villa L; De Magistris MT; Romano M; Boraschi D; Tagliabue A
    Adv Exp Med Biol; 1987; 216B():1669-75. PubMed ID: 3501237
    [No Abstract]   [Full Text] [Related]  

  • 35. Volunteer studies in the development of a live oral typhoid vaccine.
    Dima VF
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):191-8. PubMed ID: 6673697
    [No Abstract]   [Full Text] [Related]  

  • 36. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
    J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
    Tacket CO; Levine MM
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of oral killed typhoid vaccine.
    Chuttani CS; Prakash K; Vergese A; Sharma U; Singha P; Ray BG
    Bull World Health Organ; 1971; 45(4):445-50. PubMed ID: 4948415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate.
    Bellanti JA; Zeligs BJ; Vetro S; Pung YH; Luccioli S; Malavasic MJ; Hooke AM; Ubertini TR; Vanni R; Nencioni L
    Vaccine; 1993; 11(5):587-90. PubMed ID: 8488717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.